David Steven Friedman, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 105 | 2023 | 995 | 16.080 |
Why?
|
| Glaucoma, Angle-Closure | 89 | 2022 | 171 | 14.830 |
Why?
|
| Intraocular Pressure | 131 | 2023 | 1165 | 10.210 |
Why?
|
| Glaucoma, Open-Angle | 52 | 2022 | 660 | 6.910 |
Why?
|
| Refractive Errors | 26 | 2022 | 138 | 6.270 |
Why?
|
| Vision Disorders | 50 | 2021 | 1037 | 5.980 |
Why?
|
| Tonometry, Ocular | 46 | 2021 | 227 | 5.950 |
Why?
|
| Visual Acuity | 94 | 2021 | 2490 | 5.650 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 19 | 2021 | 254 | 4.860 |
Why?
|
| Visual Fields | 60 | 2022 | 1027 | 4.850 |
Why?
|
| Vision Screening | 14 | 2022 | 53 | 4.580 |
Why?
|
| Iris | 37 | 2021 | 220 | 4.140 |
Why?
|
| Gonioscopy | 64 | 2022 | 127 | 3.830 |
Why?
|
| Trabeculectomy | 20 | 2022 | 148 | 3.600 |
Why?
|
| Anterior Eye Segment | 31 | 2021 | 135 | 3.480 |
Why?
|
| Eyeglasses | 17 | 2022 | 147 | 3.450 |
Why?
|
| Iridectomy | 25 | 2021 | 41 | 3.410 |
Why?
|
| Visually Impaired Persons | 15 | 2020 | 78 | 3.320 |
Why?
|
| Refraction, Ocular | 21 | 2022 | 177 | 3.220 |
Why?
|
| Ocular Hypertension | 28 | 2022 | 189 | 3.130 |
Why?
|
| Anterior Chamber | 24 | 2021 | 196 | 2.990 |
Why?
|
| Visual Field Tests | 27 | 2022 | 374 | 2.990 |
Why?
|
| Optic Nerve Diseases | 16 | 2017 | 320 | 2.720 |
Why?
|
| Antihypertensive Agents | 26 | 2019 | 2058 | 2.600 |
Why?
|
| Eye Diseases | 17 | 2021 | 653 | 2.400 |
Why?
|
| Cataract Extraction | 20 | 2023 | 457 | 2.320 |
Why?
|
| Homes for the Aged | 8 | 2020 | 263 | 2.310 |
Why?
|
| Tomography, Optical Coherence | 59 | 2021 | 2487 | 2.290 |
Why?
|
| Pupil | 13 | 2019 | 145 | 2.220 |
Why?
|
| Ophthalmology | 15 | 2021 | 489 | 2.010 |
Why?
|
| Laser Therapy | 23 | 2022 | 1070 | 1.980 |
Why?
|
| Vision, Low | 13 | 2020 | 159 | 1.930 |
Why?
|
| Diabetic Retinopathy | 14 | 2020 | 1207 | 1.910 |
Why?
|
| Reflex, Pupillary | 5 | 2019 | 60 | 1.890 |
Why?
|
| Accidental Falls | 15 | 2022 | 1037 | 1.860 |
Why?
|
| Trabecular Meshwork | 17 | 2018 | 85 | 1.760 |
Why?
|
| Rural Population | 27 | 2020 | 2174 | 1.740 |
Why?
|
| Cataract | 19 | 2021 | 781 | 1.630 |
Why?
|
| Patient Compliance | 14 | 2019 | 2744 | 1.590 |
Why?
|
| Cloprostenol | 7 | 2013 | 22 | 1.580 |
Why?
|
| Phacoemulsification | 8 | 2023 | 139 | 1.580 |
Why?
|
| Ophthalmic Solutions | 11 | 2015 | 305 | 1.450 |
Why?
|
| Chloral Hydrate | 2 | 2018 | 29 | 1.400 |
Why?
|
| Myopia | 9 | 2022 | 250 | 1.380 |
Why?
|
| Blindness | 18 | 2022 | 598 | 1.350 |
Why?
|
| Baltimore | 14 | 2022 | 233 | 1.330 |
Why?
|
| Aged | 203 | 2022 | 162448 | 1.250 |
Why?
|
| China | 43 | 2022 | 2241 | 1.220 |
Why?
|
| Photography | 13 | 2017 | 528 | 1.190 |
Why?
|
| Vision Tests | 9 | 2020 | 156 | 1.160 |
Why?
|
| Cross-Sectional Studies | 91 | 2022 | 23438 | 1.150 |
Why?
|
| Medicare Part B | 4 | 2014 | 111 | 1.100 |
Why?
|
| Lens, Crystalline | 7 | 2021 | 421 | 1.100 |
Why?
|
| Urban Population | 12 | 2018 | 2049 | 1.060 |
Why?
|
| Prospective Studies | 88 | 2022 | 51315 | 1.060 |
Why?
|
| Male | 258 | 2022 | 350324 | 1.060 |
Why?
|
| Humans | 351 | 2023 | 715777 | 1.040 |
Why?
|
| Optic Disk | 14 | 2017 | 392 | 1.030 |
Why?
|
| Female | 260 | 2022 | 377204 | 1.030 |
Why?
|
| Mydriasis | 2 | 2022 | 12 | 1.030 |
Why?
|
| Drug Monitoring | 6 | 2014 | 939 | 1.030 |
Why?
|
| India | 18 | 2020 | 2060 | 1.020 |
Why?
|
| Middle Aged | 198 | 2022 | 214639 | 1.020 |
Why?
|
| Blister | 4 | 2020 | 92 | 1.010 |
Why?
|
| Prevalence | 61 | 2022 | 14911 | 1.010 |
Why?
|
| Conscious Sedation | 2 | 2018 | 513 | 0.970 |
Why?
|
| Reminder Systems | 3 | 2019 | 388 | 0.950 |
Why?
|
| Sickness Impact Profile | 10 | 2020 | 318 | 0.940 |
Why?
|
| Maryland | 16 | 2018 | 277 | 0.920 |
Why?
|
| Microscopy, Acoustic | 7 | 2013 | 44 | 0.910 |
Why?
|
| Medication Adherence | 8 | 2019 | 2046 | 0.910 |
Why?
|
| Schools | 7 | 2022 | 1381 | 0.900 |
Why?
|
| Pupil Disorders | 3 | 2022 | 26 | 0.890 |
Why?
|
| Lasers, Solid-State | 9 | 2021 | 178 | 0.880 |
Why?
|
| Monitoring, Ambulatory | 2 | 2021 | 354 | 0.880 |
Why?
|
| Accidents, Home | 2 | 2019 | 72 | 0.850 |
Why?
|
| Corneal Wavefront Aberration | 1 | 2021 | 6 | 0.840 |
Why?
|
| Aberrometry | 1 | 2021 | 6 | 0.840 |
Why?
|
| Health Services | 6 | 2019 | 742 | 0.840 |
Why?
|
| Retinal Ganglion Cells | 3 | 2019 | 764 | 0.800 |
Why?
|
| Aged, 80 and over | 90 | 2021 | 58323 | 0.790 |
Why?
|
| Distance Perception | 1 | 2020 | 20 | 0.780 |
Why?
|
| Diabetes Complications | 5 | 2016 | 1397 | 0.780 |
Why?
|
| Appointments and Schedules | 2 | 2021 | 430 | 0.770 |
Why?
|
| Hypnotics and Sedatives | 2 | 2018 | 1121 | 0.760 |
Why?
|
| Lens Implantation, Intraocular | 9 | 2020 | 186 | 0.760 |
Why?
|
| Reading | 7 | 2021 | 549 | 0.750 |
Why?
|
| Lighting | 2 | 2021 | 220 | 0.750 |
Why?
|
| Telemetry | 1 | 2021 | 195 | 0.750 |
Why?
|
| Prostaglandins F, Synthetic | 5 | 2014 | 31 | 0.740 |
Why?
|
| Biometry | 20 | 2022 | 543 | 0.740 |
Why?
|
| Limbus Corneae | 1 | 2021 | 135 | 0.740 |
Why?
|
| Nutrition Surveys | 7 | 2016 | 1577 | 0.740 |
Why?
|
| Conjunctiva | 3 | 2019 | 486 | 0.730 |
Why?
|
| Health Services Accessibility | 12 | 2022 | 5038 | 0.720 |
Why?
|
| Age Distribution | 23 | 2018 | 2942 | 0.700 |
Why?
|
| Allied Health Personnel | 1 | 2020 | 165 | 0.700 |
Why?
|
| Dark Adaptation | 2 | 2019 | 230 | 0.680 |
Why?
|
| Fluocinolone Acetonide | 2 | 2020 | 38 | 0.680 |
Why?
|
| Macular Degeneration | 12 | 2018 | 941 | 0.660 |
Why?
|
| Sex Distribution | 20 | 2018 | 2371 | 0.650 |
Why?
|
| Community Health Services | 4 | 2021 | 657 | 0.640 |
Why?
|
| Exercise | 11 | 2022 | 5427 | 0.640 |
Why?
|
| Cornea | 11 | 2018 | 1447 | 0.640 |
Why?
|
| Hyperopia | 4 | 2022 | 42 | 0.630 |
Why?
|
| Singapore | 20 | 2021 | 309 | 0.620 |
Why?
|
| Morbidity | 7 | 2020 | 1715 | 0.620 |
Why?
|
| Reference Standards | 1 | 2020 | 996 | 0.610 |
Why?
|
| Fear | 7 | 2021 | 1368 | 0.610 |
Why?
|
| Telemedicine | 7 | 2021 | 2608 | 0.600 |
Why?
|
| Surgical Stomas | 1 | 2016 | 45 | 0.600 |
Why?
|
| Nerve Fibers | 2 | 2019 | 708 | 0.590 |
Why?
|
| Ophthalmologic Surgical Procedures | 4 | 2022 | 335 | 0.570 |
Why?
|
| Disability Evaluation | 5 | 2020 | 1821 | 0.570 |
Why?
|
| Risk Factors | 65 | 2021 | 70866 | 0.560 |
Why?
|
| Reproducibility of Results | 28 | 2022 | 19537 | 0.530 |
Why?
|
| ROC Curve | 16 | 2021 | 3524 | 0.530 |
Why?
|
| Adult | 96 | 2023 | 212266 | 0.520 |
Why?
|
| Quality of Life | 20 | 2023 | 11721 | 0.510 |
Why?
|
| Contrast Sensitivity | 7 | 2019 | 219 | 0.510 |
Why?
|
| Telecommunications | 1 | 2014 | 83 | 0.500 |
Why?
|
| Counseling | 2 | 2021 | 1510 | 0.500 |
Why?
|
| Automobile Driving | 5 | 2020 | 412 | 0.490 |
Why?
|
| Independent Living | 1 | 2018 | 540 | 0.490 |
Why?
|
| Nursing Homes | 4 | 2005 | 967 | 0.490 |
Why?
|
| Mobility Limitation | 1 | 2018 | 405 | 0.490 |
Why?
|
| Medicare Part A | 1 | 2013 | 35 | 0.480 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 885 | 0.480 |
Why?
|
| Axial Length, Eye | 7 | 2019 | 27 | 0.460 |
Why?
|
| Blood Pressure | 7 | 2019 | 8544 | 0.460 |
Why?
|
| False Positive Reactions | 9 | 2020 | 999 | 0.450 |
Why?
|
| Patient Education as Topic | 7 | 2019 | 2330 | 0.450 |
Why?
|
| Mass Screening | 5 | 2021 | 5209 | 0.440 |
Why?
|
| Computers, Handheld | 1 | 2014 | 211 | 0.430 |
Why?
|
| Managed Care Programs | 4 | 2008 | 985 | 0.430 |
Why?
|
| Physical Examination | 1 | 2018 | 1240 | 0.430 |
Why?
|
| Activities of Daily Living | 7 | 2020 | 2316 | 0.430 |
Why?
|
| Travel | 3 | 2015 | 748 | 0.430 |
Why?
|
| Insurance Benefits | 1 | 2013 | 179 | 0.430 |
Why?
|
| Retina | 4 | 2019 | 2631 | 0.430 |
Why?
|
| Motor Activity | 5 | 2019 | 2774 | 0.420 |
Why?
|
| Amblyopia | 2 | 2010 | 123 | 0.420 |
Why?
|
| Patient Satisfaction | 11 | 2022 | 3398 | 0.410 |
Why?
|
| Mydriatics | 5 | 2022 | 70 | 0.410 |
Why?
|
| Retinal Diseases | 3 | 2012 | 669 | 0.410 |
Why?
|
| Sensitivity and Specificity | 17 | 2021 | 14902 | 0.390 |
Why?
|
| United States | 38 | 2022 | 67905 | 0.390 |
Why?
|
| Sclera | 5 | 2016 | 197 | 0.380 |
Why?
|
| Program Evaluation | 2 | 2022 | 2539 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2020 | 3959 | 0.370 |
Why?
|
| Administration, Topical | 7 | 2015 | 701 | 0.370 |
Why?
|
| Follow-Up Studies | 31 | 2021 | 39300 | 0.360 |
Why?
|
| Geographic Information Systems | 1 | 2011 | 266 | 0.360 |
Why?
|
| Physician-Patient Relations | 5 | 2015 | 3318 | 0.360 |
Why?
|
| Attitude to Health | 5 | 2011 | 2110 | 0.350 |
Why?
|
| Uveitis | 1 | 2013 | 406 | 0.350 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 250 | 0.350 |
Why?
|
| Health Surveys | 11 | 2018 | 4036 | 0.350 |
Why?
|
| Eye Injuries | 3 | 2021 | 218 | 0.340 |
Why?
|
| Glucocorticoids | 2 | 2020 | 2103 | 0.340 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 2937 | 0.340 |
Why?
|
| Actigraphy | 1 | 2012 | 452 | 0.340 |
Why?
|
| Retrospective Studies | 40 | 2022 | 72443 | 0.340 |
Why?
|
| Pseudophakia | 4 | 2020 | 61 | 0.330 |
Why?
|
| Strabismus | 3 | 2012 | 254 | 0.330 |
Why?
|
| Fundus Oculi | 3 | 2019 | 458 | 0.330 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 662 | 0.320 |
Why?
|
| Triglycerides | 1 | 2016 | 2577 | 0.320 |
Why?
|
| Drug Utilization Review | 2 | 2008 | 259 | 0.310 |
Why?
|
| Dementia | 1 | 2020 | 2258 | 0.310 |
Why?
|
| Reoperation | 5 | 2021 | 4169 | 0.310 |
Why?
|
| Fixation, Ocular | 1 | 2008 | 228 | 0.300 |
Why?
|
| Glaucoma Drainage Implants | 2 | 2021 | 106 | 0.300 |
Why?
|
| Insurance Claim Review | 3 | 2008 | 750 | 0.300 |
Why?
|
| Vision, Ocular | 4 | 2019 | 467 | 0.300 |
Why?
|
| Dyslexia | 1 | 2009 | 241 | 0.300 |
Why?
|
| Insurance, Major Medical | 1 | 2005 | 12 | 0.290 |
Why?
|
| Child | 24 | 2022 | 74468 | 0.290 |
Why?
|
| Evidence-Based Medicine | 7 | 2017 | 3683 | 0.280 |
Why?
|
| Ciliary Body | 6 | 2021 | 174 | 0.280 |
Why?
|
| Health Services for the Aged | 2 | 2005 | 263 | 0.280 |
Why?
|
| Models, Statistical | 5 | 2013 | 5064 | 0.280 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2006 | 99 | 0.280 |
Why?
|
| Universities | 1 | 2011 | 891 | 0.280 |
Why?
|
| Healthcare Disparities | 4 | 2021 | 3035 | 0.280 |
Why?
|
| Area Under Curve | 10 | 2020 | 1687 | 0.280 |
Why?
|
| Drug Utilization | 4 | 2015 | 1236 | 0.270 |
Why?
|
| Family Health | 4 | 2021 | 1289 | 0.270 |
Why?
|
| African Americans | 7 | 2018 | 5003 | 0.260 |
Why?
|
| Diabetes Mellitus | 7 | 2020 | 5463 | 0.260 |
Why?
|
| Hypertension | 4 | 2020 | 8270 | 0.260 |
Why?
|
| Movement Disorders | 1 | 2007 | 427 | 0.260 |
Why?
|
| Astigmatism | 3 | 2021 | 68 | 0.260 |
Why?
|
| Operating Rooms | 3 | 2021 | 806 | 0.250 |
Why?
|
| Population Surveillance | 4 | 2021 | 2650 | 0.240 |
Why?
|
| Young Adult | 16 | 2020 | 56226 | 0.240 |
Why?
|
| Cell Count | 3 | 2019 | 1912 | 0.240 |
Why?
|
| Bangladesh | 2 | 2019 | 799 | 0.240 |
Why?
|
| Educational Status | 6 | 2021 | 2353 | 0.230 |
Why?
|
| Vision, Binocular | 4 | 2013 | 196 | 0.230 |
Why?
|
| Communication | 4 | 2015 | 3516 | 0.230 |
Why?
|
| Cohort Studies | 18 | 2021 | 40029 | 0.230 |
Why?
|
| Physicians | 1 | 2020 | 4375 | 0.230 |
Why?
|
| Laser Coagulation | 2 | 2016 | 327 | 0.230 |
Why?
|
| Child, Preschool | 12 | 2022 | 41198 | 0.230 |
Why?
|
| Presbyopia | 1 | 2022 | 9 | 0.230 |
Why?
|
| Smoking | 3 | 2019 | 8980 | 0.230 |
Why?
|
| Predictive Value of Tests | 11 | 2020 | 15199 | 0.230 |
Why?
|
| Adolescent | 16 | 2022 | 85155 | 0.220 |
Why?
|
| Acute Disease | 7 | 2022 | 7140 | 0.220 |
Why?
|
| Manufactured Materials | 3 | 2012 | 20 | 0.220 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 7499 | 0.220 |
Why?
|
| Incidence | 15 | 2021 | 20731 | 0.220 |
Why?
|
| Drug Packaging | 2 | 2015 | 43 | 0.220 |
Why?
|
| Patient-Centered Care | 2 | 2010 | 1460 | 0.220 |
Why?
|
| School Nursing | 1 | 2021 | 34 | 0.220 |
Why?
|
| Phenylephrine | 1 | 2022 | 293 | 0.210 |
Why?
|
| Eye | 3 | 2010 | 721 | 0.210 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 1930 | 0.210 |
Why?
|
| Choroid | 3 | 2014 | 312 | 0.210 |
Why?
|
| Developing Countries | 2 | 2011 | 2737 | 0.210 |
Why?
|
| Drug Prescriptions | 3 | 2007 | 1687 | 0.210 |
Why?
|
| Age Factors | 11 | 2020 | 18784 | 0.200 |
Why?
|
| Gait | 3 | 2021 | 739 | 0.200 |
Why?
|
| Risk Assessment | 11 | 2021 | 23464 | 0.200 |
Why?
|
| Uveitis, Intermediate | 1 | 2020 | 17 | 0.200 |
Why?
|
| Disease Progression | 14 | 2021 | 13215 | 0.200 |
Why?
|
| Exfoliation Syndrome | 3 | 2018 | 114 | 0.200 |
Why?
|
| Panuveitis | 1 | 2020 | 32 | 0.200 |
Why?
|
| Filtering Surgery | 2 | 2015 | 35 | 0.190 |
Why?
|
| Uveitis, Posterior | 1 | 2020 | 47 | 0.190 |
Why?
|
| Aging | 6 | 2018 | 8350 | 0.190 |
Why?
|
| Health Care Costs | 2 | 2013 | 3164 | 0.190 |
Why?
|
| Health Promotion | 3 | 2022 | 2212 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2021 | 9596 | 0.190 |
Why?
|
| Color Vision | 1 | 2019 | 20 | 0.190 |
Why?
|
| Economics, Medical | 1 | 2020 | 111 | 0.190 |
Why?
|
| Odds Ratio | 8 | 2019 | 9984 | 0.190 |
Why?
|
| Video Recording | 5 | 2012 | 944 | 0.190 |
Why?
|
| Siblings | 3 | 2021 | 820 | 0.180 |
Why?
|
| Hospitals, Special | 1 | 2020 | 111 | 0.180 |
Why?
|
| Lenses, Intraocular | 2 | 2019 | 136 | 0.180 |
Why?
|
| Suture Techniques | 2 | 2019 | 792 | 0.180 |
Why?
|
| Light | 6 | 2012 | 1434 | 0.180 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1937 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2018 | 15603 | 0.170 |
Why?
|
| Hospitals, Rural | 3 | 2015 | 156 | 0.170 |
Why?
|
| Infant | 10 | 2021 | 34569 | 0.170 |
Why?
|
| Manometry | 1 | 2020 | 416 | 0.170 |
Why?
|
| Biomedical Technology | 1 | 2021 | 219 | 0.170 |
Why?
|
| Functional Laterality | 4 | 2010 | 2288 | 0.170 |
Why?
|
| Optometry | 1 | 2017 | 27 | 0.170 |
Why?
|
| Prone Position | 1 | 2019 | 192 | 0.160 |
Why?
|
| Self Report | 2 | 2020 | 3416 | 0.160 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 421 | 0.160 |
Why?
|
| Parents | 4 | 2021 | 3178 | 0.160 |
Why?
|
| School Health Services | 1 | 2021 | 380 | 0.160 |
Why?
|
| Postal Service | 1 | 2017 | 102 | 0.160 |
Why?
|
| Prescriptions | 2 | 2017 | 347 | 0.160 |
Why?
|
| Drug Implants | 2 | 2020 | 241 | 0.160 |
Why?
|
| Delaware | 3 | 2005 | 15 | 0.160 |
Why?
|
| Databases, Factual | 8 | 2020 | 7895 | 0.160 |
Why?
|
| Trust | 1 | 2021 | 493 | 0.160 |
Why?
|
| Observer Variation | 9 | 2019 | 2676 | 0.150 |
Why?
|
| Heart Rate | 2 | 2018 | 4097 | 0.150 |
Why?
|
| Treatment Outcome | 18 | 2022 | 62004 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 2 | 2019 | 2260 | 0.150 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 1755 | 0.150 |
Why?
|
| Genome-Wide Association Study | 5 | 2018 | 11940 | 0.150 |
Why?
|
| Research Design | 6 | 2017 | 5902 | 0.140 |
Why?
|
| Self Care | 1 | 2021 | 795 | 0.140 |
Why?
|
| Sex Factors | 9 | 2020 | 10666 | 0.140 |
Why?
|
| Insurance, Health | 3 | 2018 | 2497 | 0.140 |
Why?
|
| Longitudinal Studies | 10 | 2022 | 13643 | 0.140 |
Why?
|
| Fluorouracil | 3 | 2016 | 1610 | 0.130 |
Why?
|
| Scotoma | 1 | 2016 | 130 | 0.130 |
Why?
|
| Postural Balance | 1 | 2020 | 640 | 0.130 |
Why?
|
| Geographic Atrophy | 1 | 2015 | 57 | 0.130 |
Why?
|
| Case-Control Studies | 10 | 2021 | 21797 | 0.130 |
Why?
|
| Interferometry | 2 | 2012 | 98 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 228 | 0.130 |
Why?
|
| Caveolin 2 | 1 | 2013 | 26 | 0.130 |
Why?
|
| Therapies, Investigational | 1 | 2015 | 113 | 0.130 |
Why?
|
| Keratoconus | 1 | 2015 | 107 | 0.130 |
Why?
|
| Wnt Proteins | 1 | 2018 | 725 | 0.120 |
Why?
|
| Equipment Safety | 1 | 2015 | 274 | 0.120 |
Why?
|
| Photic Stimulation | 2 | 2013 | 2014 | 0.120 |
Why?
|
| Double-Blind Method | 4 | 2013 | 11945 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 1418 | 0.120 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 62 | 0.120 |
Why?
|
| Pterygium | 1 | 2013 | 19 | 0.120 |
Why?
|
| Needles | 1 | 2016 | 443 | 0.120 |
Why?
|
| Postoperative Complications | 7 | 2022 | 15079 | 0.120 |
Why?
|
| Clinical Competence | 3 | 2015 | 4630 | 0.120 |
Why?
|
| Reflex, Abnormal | 1 | 2013 | 85 | 0.120 |
Why?
|
| Injections | 1 | 2016 | 867 | 0.120 |
Why?
|
| Referral and Consultation | 2 | 2019 | 3451 | 0.120 |
Why?
|
| Wet Macular Degeneration | 1 | 2015 | 132 | 0.120 |
Why?
|
| Probability | 3 | 2013 | 2487 | 0.120 |
Why?
|
| Obesity, Abdominal | 1 | 2016 | 335 | 0.120 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 286 | 0.110 |
Why?
|
| Lens Diseases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2013 | 68 | 0.110 |
Why?
|
| Nystagmus, Congenital | 1 | 2012 | 7 | 0.110 |
Why?
|
| Time Factors | 14 | 2020 | 40875 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2019 | 4279 | 0.110 |
Why?
|
| Comparative Effectiveness Research | 2 | 2015 | 689 | 0.110 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 652 | 0.110 |
Why?
|
| False Negative Reactions | 1 | 2013 | 604 | 0.110 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 126 | 0.110 |
Why?
|
| Caveolin 1 | 1 | 2013 | 258 | 0.110 |
Why?
|
| Child Health Services | 1 | 2018 | 683 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 857 | 0.110 |
Why?
|
| Cell Size | 1 | 2013 | 658 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2018 | 722 | 0.100 |
Why?
|
| Students | 3 | 2021 | 1563 | 0.100 |
Why?
|
| Artificial Intelligence | 2 | 2020 | 1744 | 0.100 |
Why?
|
| Hospitals | 2 | 2022 | 3375 | 0.100 |
Why?
|
| Amides | 2 | 2011 | 449 | 0.100 |
Why?
|
| Hypotension | 1 | 2016 | 828 | 0.100 |
Why?
|
| Endothelium, Corneal | 1 | 2012 | 188 | 0.100 |
Why?
|
| Education, Medical, Graduate | 2 | 2013 | 2207 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 1 | 2014 | 649 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 1976 | 0.100 |
Why?
|
| Health Services Research | 3 | 2007 | 1840 | 0.100 |
Why?
|
| Focus Groups | 3 | 2021 | 1264 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2018 | 3956 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2016 | 2677 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2006 | 3268 | 0.100 |
Why?
|
| Health Behavior | 2 | 2014 | 2623 | 0.100 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 220 | 0.090 |
Why?
|
| Surgically-Created Structures | 1 | 2009 | 8 | 0.090 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 522 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1646 | 0.090 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 12480 | 0.090 |
Why?
|
| Retinal Vessels | 1 | 2015 | 763 | 0.090 |
Why?
|
| Macula Lutea | 1 | 2010 | 140 | 0.090 |
Why?
|
| Eyelids | 1 | 2011 | 253 | 0.090 |
Why?
|
| Regression Analysis | 3 | 2013 | 6495 | 0.090 |
Why?
|
| Rural Health Services | 1 | 2013 | 381 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1738 | 0.090 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3902 | 0.090 |
Why?
|
| Epiretinal Membrane | 1 | 2008 | 66 | 0.090 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2008 | 23 | 0.090 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 1385 | 0.080 |
Why?
|
| Consensus | 1 | 2017 | 2743 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 15909 | 0.080 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 695 | 0.080 |
Why?
|
| Iris Diseases | 1 | 2007 | 29 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6722 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 1412 | 0.080 |
Why?
|
| Minority Groups | 1 | 2015 | 1088 | 0.080 |
Why?
|
| Medicare | 2 | 2022 | 5791 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 9004 | 0.080 |
Why?
|
| Movement | 1 | 2015 | 1473 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2016 | 12535 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 781 | 0.080 |
Why?
|
| Body Height | 1 | 2014 | 1609 | 0.080 |
Why?
|
| Income | 1 | 2016 | 1822 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2019 | 2030 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2768 | 0.080 |
Why?
|
| Algorithms | 5 | 2017 | 13758 | 0.080 |
Why?
|
| Corneal Diseases | 1 | 2013 | 596 | 0.070 |
Why?
|
| Blood Glucose | 4 | 2014 | 6259 | 0.070 |
Why?
|
| Nuclear Family | 1 | 2007 | 311 | 0.070 |
Why?
|
| Ultrasonography | 6 | 2021 | 5922 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2012 | 986 | 0.070 |
Why?
|
| Estrogens | 1 | 2013 | 1529 | 0.070 |
Why?
|
| Decision Making | 2 | 2019 | 3846 | 0.070 |
Why?
|
| Adiposity | 1 | 2016 | 1757 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2021 | 9030 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1778 | 0.070 |
Why?
|
| Geriatric Assessment | 2 | 2014 | 1312 | 0.070 |
Why?
|
| Asia | 3 | 2015 | 643 | 0.070 |
Why?
|
| Medicaid | 1 | 2018 | 2649 | 0.070 |
Why?
|
| Organ Size | 3 | 2018 | 2278 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2005 | 498 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1437 | 0.060 |
Why?
|
| Exercise Test | 1 | 2012 | 2110 | 0.060 |
Why?
|
| Aphakia, Postcataract | 1 | 2004 | 47 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 2554 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1974 | 0.060 |
Why?
|
| Miotics | 1 | 2003 | 8 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 868 | 0.060 |
Why?
|
| Veterans | 1 | 2016 | 2237 | 0.060 |
Why?
|
| Uvea | 1 | 2003 | 30 | 0.060 |
Why?
|
| Pilocarpine | 1 | 2003 | 69 | 0.060 |
Why?
|
| Specialization | 1 | 2008 | 789 | 0.060 |
Why?
|
| Republic of Korea | 2 | 2016 | 581 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2013 | 17409 | 0.060 |
Why?
|
| Body Weight | 1 | 2014 | 4688 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2550 | 0.060 |
Why?
|
| Glucose | 1 | 2014 | 4273 | 0.060 |
Why?
|